Glucoză Plasco B. Braun (Glucose Monohydrate)

Glucoză Plasco B. Braun is employed in several clinical situations where rapid glucose replacement is needed. It is commonly used for:

• Intravenous fluid therapy to correct hypoglycemia.
• Providing caloric support during peri‑operative care.
• Managing metabolic emergencies such as insulin overdose.
• Supplementing nutrition in patients unable to ingest food orally.
• Supporting electrolyte balance when combined with appropriate salts.

Side effects of glucose monohydrate solutions are generally related to the route of administration and the osmolarity of the product.

Common

• Local irritation at the infusion site.
• Transient hyperglycemia.
• Fluid overload in susceptible patients.
• Electrolyte shifts, especially potassium.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reactions such as rash or anaphylaxis.
• Pulmonary edema in patients with cardiac dysfunction.
• Metabolic acidosis if administered in excess.

When using Glucoză Plasco B. Braun, healthcare professionals should observe several safety measures:

• Verify patient blood glucose levels before administration.
• Adjust infusion rate in patients with renal or cardiac impairment.
• Monitor for signs of fluid overload during prolonged therapy.
• Use aseptic technique to prevent contamination.
• Avoid rapid bolus administration unless clinically indicated.
• Document any adverse reactions promptly.

Glucose solutions can interact with other medications and clinical conditions. Awareness of these interactions helps prevent complications.

Avoid

• Co‑administration with high‑dose insulin without glucose monitoring.
• Simultaneous infusion of hypertonic solutions that may exacerbate hyperglycemia.

Use with caution

• Concurrent use of diuretics that affect fluid balance.
• Medications that alter potassium levels, such as ACE inhibitors.
• Patients receiving total parenteral nutrition (TPN) formulations.
• Drugs that may cause hypoglycemia, requiring closer glucose surveillance.